NALCN and cancer: To determine how nonsynonymous mutations might affect NALCN function in cancer, we used HOLE analysis21 to predict their impact on the ion channel pore radius of NALCN embedded and relaxed within a 575-lipid 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine bilayer in silico12,22,23.